Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
Although hyperhomocysteinemia (hHcys) has been recognized as an important independent risk factor in the progression of end-stage renal disease and the development of cardiovascular complications related to end-stage renal disease, the mechanisms triggering pathogenic actions of hHcys are not fully...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661823003651 |
_version_ | 1797422659083960320 |
---|---|
author | Min Liu Yang Zhang Ping Zhan Wenjuan Sun Chuanqiao Dong Xiaohan Liu Yujie Yang Xiaojie Wang Yusheng Xie Chengjiang Gao Huili Hu Benkang Shi Ziying Wang Chun Guo Fan Yi |
author_facet | Min Liu Yang Zhang Ping Zhan Wenjuan Sun Chuanqiao Dong Xiaohan Liu Yujie Yang Xiaojie Wang Yusheng Xie Chengjiang Gao Huili Hu Benkang Shi Ziying Wang Chun Guo Fan Yi |
author_sort | Min Liu |
collection | DOAJ |
description | Although hyperhomocysteinemia (hHcys) has been recognized as an important independent risk factor in the progression of end-stage renal disease and the development of cardiovascular complications related to end-stage renal disease, the mechanisms triggering pathogenic actions of hHcys are not fully understood. The present study was mainly designed to investigate the role of HDACs in renal injury induced by hHcys. Firstly, we identified the expression patterns of HDACs and found that, among zinc-dependent HDACs, HDAC9 was preferentially upregulated in the kidney from mice with hHcys. Deficiency or pharmacological inhibition of HDAC9 ameliorated renal injury in mice with hHcys. Moreover, podocyte-specific deletion of HDAC9 significantly attenuated podocyte injury and proteinuria. In vitro, gene silencing of HDAC9 attenuated podocyte injury by inhibiting apoptosis, reducing oxidative stress and maintaining the expressions of podocyte slit diaphragm proteins. Mechanically, we proved for the first time that HDAC9 reduced the acetylation level of H3K9 in the promoter of Klotho, then inhibited gene transcription of Klotho, finally aggravating podocyte injury in hHcys. In conclusion, our results indicated that targeting of HDAC9 might be an attractive therapeutic strategy for the treatment of renal injury induced by hHcys. |
first_indexed | 2024-03-09T07:36:33Z |
format | Article |
id | doaj.art-b75d1c61ff964de882682ddef23b59b2 |
institution | Directory Open Access Journal |
issn | 1096-1186 |
language | English |
last_indexed | 2024-03-09T07:36:33Z |
publishDate | 2023-12-01 |
publisher | Elsevier |
record_format | Article |
series | Pharmacological Research |
spelling | doaj.art-b75d1c61ff964de882682ddef23b59b22023-12-03T05:39:43ZengElsevierPharmacological Research1096-11862023-12-01198107009Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of KlothoMin Liu0Yang Zhang1Ping Zhan2Wenjuan Sun3Chuanqiao Dong4Xiaohan Liu5Yujie Yang6Xiaojie Wang7Yusheng Xie8Chengjiang Gao9Huili Hu10Benkang Shi11Ziying Wang12Chun Guo13Fan Yi14Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Obstetrics, the Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaThe Key Laboratory of Infection and Immunity of Shandong Province, Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaThe Key Laboratory of Experimental Teratology, Ministry of Education, Department of Molecular Medicine and Genetics, School of Basic Medical Sciences, Shandong University, Jinan 250012, ChinaDepartment of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, ChinaDepartment of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, China; Corresponding authors.School of Basic Medical Sciences, Shandong University, Jinan 250012, China; Corresponding authors.Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, China; Corresponding authors.Although hyperhomocysteinemia (hHcys) has been recognized as an important independent risk factor in the progression of end-stage renal disease and the development of cardiovascular complications related to end-stage renal disease, the mechanisms triggering pathogenic actions of hHcys are not fully understood. The present study was mainly designed to investigate the role of HDACs in renal injury induced by hHcys. Firstly, we identified the expression patterns of HDACs and found that, among zinc-dependent HDACs, HDAC9 was preferentially upregulated in the kidney from mice with hHcys. Deficiency or pharmacological inhibition of HDAC9 ameliorated renal injury in mice with hHcys. Moreover, podocyte-specific deletion of HDAC9 significantly attenuated podocyte injury and proteinuria. In vitro, gene silencing of HDAC9 attenuated podocyte injury by inhibiting apoptosis, reducing oxidative stress and maintaining the expressions of podocyte slit diaphragm proteins. Mechanically, we proved for the first time that HDAC9 reduced the acetylation level of H3K9 in the promoter of Klotho, then inhibited gene transcription of Klotho, finally aggravating podocyte injury in hHcys. In conclusion, our results indicated that targeting of HDAC9 might be an attractive therapeutic strategy for the treatment of renal injury induced by hHcys.http://www.sciencedirect.com/science/article/pii/S1043661823003651HDAC9EpigeneticKlothoPodocyteHyperhomocysteinemia |
spellingShingle | Min Liu Yang Zhang Ping Zhan Wenjuan Sun Chuanqiao Dong Xiaohan Liu Yujie Yang Xiaojie Wang Yusheng Xie Chengjiang Gao Huili Hu Benkang Shi Ziying Wang Chun Guo Fan Yi Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho Pharmacological Research HDAC9 Epigenetic Klotho Podocyte Hyperhomocysteinemia |
title | Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho |
title_full | Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho |
title_fullStr | Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho |
title_full_unstemmed | Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho |
title_short | Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho |
title_sort | histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of klotho |
topic | HDAC9 Epigenetic Klotho Podocyte Hyperhomocysteinemia |
url | http://www.sciencedirect.com/science/article/pii/S1043661823003651 |
work_keys_str_mv | AT minliu histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT yangzhang histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT pingzhan histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT wenjuansun histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT chuanqiaodong histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT xiaohanliu histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT yujieyang histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT xiaojiewang histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT yushengxie histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT chengjianggao histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT huilihu histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT benkangshi histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT ziyingwang histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT chunguo histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho AT fanyi histonedeacetylase9exacerbatespodocyteinjuryinhyperhomocysteinemiathroughepigeneticrepressionofklotho |